Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Place An Ad | All Access E-Edition | Home RSS
 
 
 

Legislation is ‘Right to Try’

June 11, 2014
By WALTER WILLIAMS , Creators Syndicate

Darcy Olsen, president of the Arizona-based Goldwater Institute, and Richard Garr, president of Neuralstem, a biotech company, wrote "Right to Try experimental drugs" in USA Today (5/28/2014). They pointed out that "this year, more than 5,000 Americans will lose their battle with ALS, commonly known as Lou Gehrig's disease." Up until recently, there was no medicine on the market that significantly improved the lives of ALS patients. But now there is one in clinical trials that holds considerable promise, but it has not been granted Food and Drug Administration approval. The average amount of time it takes to get a drug through the FDA approval process is 10 years. That's time that terminal patients don't have.

 
 

 

I am looking for: